1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Contrary To Trump, Gottlieb Says The US Had ‘Late Start’ Testing For COVID-19

Despite the White House’s insistence it has been quick and decisive in its response to the COVID-19 crisis, former FDA commissioner Scott Gottlieb – who has been advising the administration – said on 6 May that the government should’ve responded months sooner to ensure there was enough testing.

President Trump and Scott Gottlieb
Donald Trump and Scott Gottlieb

Despite President Trump’s insistence his administration has been proactive in its response to the current coronavirus pandemic, a former US Food and Drug Administration commissioner who has been unofficially helping the White House deal with the crisis said the country should have responded with tests much sooner.

During a 6 May webcast interview with The Washington Post, former FDA commissioner Scott Gottlieb said the US should have taken steps to develop diagnostics tests for SARS-CoV-2 back in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 
• By Amanda Maxwell

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 
• By Brian Bossetta

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.